Smith+Nephew completed the acquisition of the Extremity Orthopaedics business of Integra LifeSciences for $240m.

Smith+Nephew, the global medical technology business, completed the acquisition of the Extremity Orthopaedics business of Integra LifeSciences, a global medical technology company, for $240m. "We are excited to secure this established global business in the rapidly growing extremities segment. Its portfolio, specialised sales channel and product pipeline all strengthen our business and we look forward to welcoming our new colleagues to Smith+Nephew," Skip Kiil, Smith+Nephew Global Orthopaedics President.